nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—SLC22A4—glottis—head and neck cancer	0.0875	0.167	CbGeAlD
L-Arginine—SLC22A4—larynx—head and neck cancer	0.0309	0.0593	CbGeAlD
L-Arginine—Skin necrosis—Hydroxyurea—head and neck cancer	0.0306	0.112	CcSEcCtD
L-Arginine—ASS1—hair follicle—head and neck cancer	0.0192	0.0368	CbGeAlD
L-Arginine—ARG2—neck—head and neck cancer	0.0184	0.0352	CbGeAlD
L-Arginine—Platelet count decreased—Hydroxyurea—head and neck cancer	0.018	0.0658	CcSEcCtD
L-Arginine—AZIN2—thyroid gland—head and neck cancer	0.0168	0.0322	CbGeAlD
L-Arginine—ASL—thyroid gland—head and neck cancer	0.0156	0.0299	CbGeAlD
L-Arginine—SLC7A4—head—head and neck cancer	0.0155	0.0298	CbGeAlD
L-Arginine—ARG2—parotid gland—head and neck cancer	0.015	0.0287	CbGeAlD
L-Arginine—ARG2—saliva-secreting gland—head and neck cancer	0.0144	0.0275	CbGeAlD
L-Arginine—Numbness—Vinblastine—head and neck cancer	0.0142	0.0518	CcSEcCtD
L-Arginine—ASL—head—head and neck cancer	0.0139	0.0265	CbGeAlD
L-Arginine—Sensory loss—Vinblastine—head and neck cancer	0.0135	0.0496	CcSEcCtD
L-Arginine—Extravasation—Vinblastine—head and neck cancer	0.0134	0.0492	CcSEcCtD
L-Arginine—NOS3—neck—head and neck cancer	0.0129	0.0246	CbGeAlD
L-Arginine—ARG2—epithelium—head and neck cancer	0.0125	0.024	CbGeAlD
L-Arginine—ARG2—trachea—head and neck cancer	0.0111	0.0212	CbGeAlD
L-Arginine—ASS1—parotid gland—head and neck cancer	0.0105	0.0201	CbGeAlD
L-Arginine—AZIN2—lymph node—head and neck cancer	0.0104	0.02	CbGeAlD
L-Arginine—SLC7A1—thyroid gland—head and neck cancer	0.0102	0.0196	CbGeAlD
L-Arginine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0102	0.0374	CcSEcCtD
L-Arginine—ASS1—saliva-secreting gland—head and neck cancer	0.0101	0.0193	CbGeAlD
L-Arginine—Necrosis—Fluorouracil—head and neck cancer	0.00981	0.0359	CcSEcCtD
L-Arginine—ASL—lymph node—head and neck cancer	0.0097	0.0186	CbGeAlD
L-Arginine—Numbness—Fluorouracil—head and neck cancer	0.00929	0.034	CcSEcCtD
L-Arginine—NOS3—connective tissue—head and neck cancer	0.00921	0.0176	CbGeAlD
L-Arginine—SLC16A10—neck—head and neck cancer	0.00921	0.0176	CbGeAlD
L-Arginine—SLC7A1—head—head and neck cancer	0.00908	0.0174	CbGeAlD
L-Arginine—Sensory loss—Fluorouracil—head and neck cancer	0.00889	0.0325	CcSEcCtD
L-Arginine—Extravasation—Fluorouracil—head and neck cancer	0.00883	0.0323	CcSEcCtD
L-Arginine—ASS1—epithelium—head and neck cancer	0.00877	0.0168	CbGeAlD
L-Arginine—ARG2—thyroid gland—head and neck cancer	0.00876	0.0168	CbGeAlD
L-Arginine—NOS3—epithelium—head and neck cancer	0.00875	0.0167	CbGeAlD
L-Arginine—SLC22A4—neck—head and neck cancer	0.0082	0.0157	CbGeAlD
L-Arginine—ARG2—head—head and neck cancer	0.00777	0.0149	CbGeAlD
L-Arginine—ASS1—trachea—head and neck cancer	0.00776	0.0149	CbGeAlD
L-Arginine—NOS3—trachea—head and neck cancer	0.00773	0.0148	CbGeAlD
L-Arginine—SLC16A10—parotid gland—head and neck cancer	0.0075	0.0144	CbGeAlD
L-Arginine—Necrosis—Docetaxel—head and neck cancer	0.00708	0.0259	CcSEcCtD
L-Arginine—NOS3—lymphoid tissue—head and neck cancer	0.00674	0.0129	CbGeAlD
L-Arginine—Extravasation—Docetaxel—head and neck cancer	0.00637	0.0233	CcSEcCtD
L-Arginine—SLC7A1—lymph node—head and neck cancer	0.00636	0.0122	CbGeAlD
L-Arginine—Swelling—Fluorouracil—head and neck cancer	0.00634	0.0232	CcSEcCtD
L-Arginine—SLC16A10—epithelium—head and neck cancer	0.00627	0.012	CbGeAlD
L-Arginine—NOS2—IL12-mediated signaling events—STAT6—head and neck cancer	0.00618	0.0302	CbGpPWpGaD
L-Arginine—ASS1—thyroid gland—head and neck cancer	0.00614	0.0118	CbGeAlD
L-Arginine—NOS3—thyroid gland—head and neck cancer	0.00612	0.0117	CbGeAlD
L-Arginine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00586	0.0215	CcSEcCtD
L-Arginine—Lethargy—Fluorouracil—head and neck cancer	0.0057	0.0209	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—head and neck cancer	0.00553	0.0202	CcSEcCtD
L-Arginine—ASS1—head—head and neck cancer	0.00545	0.0104	CbGeAlD
L-Arginine—ARG2—lymph node—head and neck cancer	0.00544	0.0104	CbGeAlD
L-Arginine—NOS3—head—head and neck cancer	0.00543	0.0104	CbGeAlD
L-Arginine—Skin exfoliation—Docetaxel—head and neck cancer	0.00531	0.0194	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—YAP1—head and neck cancer	0.00501	0.0245	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—RAD51—head and neck cancer	0.00501	0.0245	CbGpPWpGaD
L-Arginine—SLC22A4—trachea—head and neck cancer	0.00494	0.00945	CbGeAlD
L-Arginine—SLC16A10—lymphoid tissue—head and neck cancer	0.00483	0.00924	CbGeAlD
L-Arginine—Swelling—Docetaxel—head and neck cancer	0.00457	0.0167	CcSEcCtD
L-Arginine—SLC22A5—parotid gland—head and neck cancer	0.00442	0.00847	CbGeAlD
L-Arginine—SLC16A10—thyroid gland—head and neck cancer	0.00438	0.0084	CbGeAlD
L-Arginine—SLC22A5—saliva-secreting gland—head and neck cancer	0.00423	0.00811	CbGeAlD
L-Arginine—Lethargy—Docetaxel—head and neck cancer	0.00412	0.0151	CcSEcCtD
L-Arginine—Anorexia—Vinblastine—head and neck cancer	0.00399	0.0146	CcSEcCtD
L-Arginine—AZIN2—Metabolism—UROD—head and neck cancer	0.00396	0.0194	CbGpPWpGaD
L-Arginine—SLC22A4—thyroid gland—head and neck cancer	0.00391	0.00748	CbGeAlD
L-Arginine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00385	0.0141	CcSEcCtD
L-Arginine—ASS1—lymph node—head and neck cancer	0.00381	0.0073	CbGeAlD
L-Arginine—NOS3—lymph node—head and neck cancer	0.0038	0.00728	CbGeAlD
L-Arginine—Anorexia—Hydroxyurea—head and neck cancer	0.00364	0.0133	CcSEcCtD
L-Arginine—Decreased appetite—Vinblastine—head and neck cancer	0.00364	0.0133	CcSEcCtD
L-Arginine—ASL—Metabolism—UROD—head and neck cancer	0.00362	0.0177	CbGpPWpGaD
L-Arginine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00332	0.0121	CcSEcCtD
L-Arginine—SLC22A5—trachea—head and neck cancer	0.00327	0.00626	CbGeAlD
L-Arginine—NOS3—eNOS activation—AKT1—head and neck cancer	0.00326	0.0159	CbGpPWpGaD
L-Arginine—Hypersensitivity—Vinblastine—head and neck cancer	0.00308	0.0113	CcSEcCtD
L-Arginine—ARG2—Metabolism—UROD—head and neck cancer	0.003	0.0147	CbGpPWpGaD
L-Arginine—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—head and neck cancer	0.00291	0.0142	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—head and neck cancer	0.00282	0.0138	CbGpPWpGaD
L-Arginine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00281	0.0103	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—BCL2L1—head and neck cancer	0.00279	0.0136	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00278	0.0102	CcSEcCtD
L-Arginine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00275	0.0101	CcSEcCtD
L-Arginine—SLC16A10—lymph node—head and neck cancer	0.00272	0.00522	CbGeAlD
L-Arginine—Tachycardia—Fluorouracil—head and neck cancer	0.00268	0.00981	CcSEcCtD
L-Arginine—Vomiting—Vinblastine—head and neck cancer	0.00266	0.00974	CcSEcCtD
L-Arginine—Headache—Vinblastine—head and neck cancer	0.00262	0.0096	CcSEcCtD
L-Arginine—Anorexia—Fluorouracil—head and neck cancer	0.00262	0.00959	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00262	0.0128	CbGpPWpGaD
L-Arginine—Flushing—Docetaxel—head and neck cancer	0.00259	0.00948	CcSEcCtD
L-Arginine—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—head and neck cancer	0.00259	0.0127	CbGpPWpGaD
L-Arginine—SLC22A5—thyroid gland—head and neck cancer	0.00258	0.00495	CbGeAlD
L-Arginine—NOS2—IL23-mediated signaling events—IL2—head and neck cancer	0.0025	0.0122	CbGpPWpGaD
L-Arginine—Nausea—Vinblastine—head and neck cancer	0.00249	0.0091	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00243	0.0119	CbGpPWpGaD
L-Arginine—Vomiting—Hydroxyurea—head and neck cancer	0.00243	0.00888	CcSEcCtD
L-Arginine—SLC22A4—lymph node—head and neck cancer	0.00243	0.00465	CbGeAlD
L-Arginine—Rash—Hydroxyurea—head and neck cancer	0.00241	0.00881	CcSEcCtD
L-Arginine—Dermatitis—Hydroxyurea—head and neck cancer	0.0024	0.0088	CcSEcCtD
L-Arginine—Headache—Hydroxyurea—head and neck cancer	0.00239	0.00875	CcSEcCtD
L-Arginine—Decreased appetite—Fluorouracil—head and neck cancer	0.00239	0.00874	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—VEGFA—head and neck cancer	0.00233	0.0114	CbGpPWpGaD
L-Arginine—Nausea—Hydroxyurea—head and neck cancer	0.00227	0.0083	CcSEcCtD
L-Arginine—NOS2—IL23-mediated signaling events—STAT3—head and neck cancer	0.0021	0.0103	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—MAPK1—head and neck cancer	0.0021	0.0103	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—CASP8—head and neck cancer	0.00208	0.0102	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—UROD—head and neck cancer	0.00208	0.0102	CbGpPWpGaD
L-Arginine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00202	0.00741	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—VEGFA—head and neck cancer	0.002	0.00979	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00198	0.00726	CcSEcCtD
L-Arginine—NOS2—ATF-2 transcription factor network—BCL2—head and neck cancer	0.00195	0.00955	CbGpPWpGaD
L-Arginine—Tachycardia—Docetaxel—head and neck cancer	0.00194	0.00708	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—MAPK3—head and neck cancer	0.0019	0.00926	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—head and neck cancer	0.00189	0.00924	CbGpPWpGaD
L-Arginine—Anorexia—Docetaxel—head and neck cancer	0.00189	0.00692	CcSEcCtD
L-Arginine—NOS3—Angiogenesis—PIK3CA—head and neck cancer	0.00182	0.0089	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—MAPK1—head and neck cancer	0.0018	0.00881	CbGpPWpGaD
L-Arginine—NOS3—Metabolism of nitric oxide—AKT1—head and neck cancer	0.00179	0.00876	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—BCL2L1—head and neck cancer	0.00178	0.00872	CbGpPWpGaD
L-Arginine—Vomiting—Fluorouracil—head and neck cancer	0.00175	0.00639	CcSEcCtD
L-Arginine—Rash—Fluorouracil—head and neck cancer	0.00173	0.00634	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—head and neck cancer	0.00173	0.00633	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—head and neck cancer	0.00172	0.00631	CcSEcCtD
L-Arginine—Headache—Fluorouracil—head and neck cancer	0.00172	0.0063	CcSEcCtD
L-Arginine—NOS2—IL12-mediated signaling events—IL2—head and neck cancer	0.0017	0.0083	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.00168	0.0082	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CCND1—head and neck cancer	0.00168	0.0082	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00166	0.00811	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—NAT2—head and neck cancer	0.00164	0.00804	CbGpPWpGaD
L-Arginine—Nausea—Fluorouracil—head and neck cancer	0.00163	0.00597	CcSEcCtD
L-Arginine—NOS3—Endothelin Pathways—MAPK1—head and neck cancer	0.00163	0.00795	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—CASP8—head and neck cancer	0.00162	0.0079	CbGpPWpGaD
L-Arginine—SLC22A5—lymph node—head and neck cancer	0.00161	0.00307	CbGeAlD
L-Arginine—NOS3—VEGFR1 specific signals—PIK3CA—head and neck cancer	0.00157	0.00765	CbGpPWpGaD
L-Arginine—ASL—Metabolism—NAT2—head and neck cancer	0.0015	0.00735	CbGpPWpGaD
L-Arginine—NOS3—Angiogenesis—AKT1—head and neck cancer	0.00149	0.00727	CbGpPWpGaD
L-Arginine—Hypersensitivity—Docetaxel—head and neck cancer	0.00146	0.00535	CcSEcCtD
L-Arginine—AZIN2—Metabolism—DPYD—head and neck cancer	0.00144	0.00705	CbGpPWpGaD
L-Arginine—NOS2—IL12-mediated signaling events—STAT3—head and neck cancer	0.00143	0.00698	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.00138	0.00676	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—YAP1—head and neck cancer	0.00137	0.00669	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL2—head and neck cancer	0.00135	0.00662	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.00134	0.00653	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—STAT3—head and neck cancer	0.00132	0.00647	CbGpPWpGaD
L-Arginine—ASL—Metabolism—DPYD—head and neck cancer	0.00132	0.00645	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.00132	0.00643	CbGpPWpGaD
L-Arginine—NOS3—VEGFR2 mediated vascular permeability—AKT1—head and neck cancer	0.00131	0.00643	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—STAT3—head and neck cancer	0.00131	0.00639	CbGpPWpGaD
L-Arginine—NOS3—VEGFR1 specific signals—AKT1—head and neck cancer	0.00128	0.00625	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MAPK3—head and neck cancer	0.00126	0.00618	CbGpPWpGaD
L-Arginine—Vomiting—Docetaxel—head and neck cancer	0.00126	0.00461	CcSEcCtD
L-Arginine—ASL—Metabolism—YAP1—head and neck cancer	0.00125	0.00612	CbGpPWpGaD
L-Arginine—Rash—Docetaxel—head and neck cancer	0.00125	0.00458	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—TYMS—head and neck cancer	0.00125	0.00611	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MAPK3—head and neck cancer	0.00125	0.00611	CbGpPWpGaD
L-Arginine—Dermatitis—Docetaxel—head and neck cancer	0.00125	0.00457	CcSEcCtD
L-Arginine—ARG2—Metabolism—NAT2—head and neck cancer	0.00125	0.00609	CbGpPWpGaD
L-Arginine—Headache—Docetaxel—head and neck cancer	0.00124	0.00455	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MAPK3—head and neck cancer	0.00123	0.00599	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—MAPK1—head and neck cancer	0.0012	0.00588	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—EGFR—head and neck cancer	0.0012	0.00588	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MAPK1—head and neck cancer	0.00119	0.00581	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—head and neck cancer	0.00119	0.00581	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—PIK3CA—head and neck cancer	0.00119	0.0058	CbGpPWpGaD
L-Arginine—Nausea—Docetaxel—head and neck cancer	0.00118	0.00431	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—MAPK1—head and neck cancer	0.00117	0.0057	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—VEGFA—head and neck cancer	0.00115	0.00562	CbGpPWpGaD
L-Arginine—NOS3—PAR1-mediated thrombin signaling events—PIK3CA—head and neck cancer	0.00114	0.00558	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00114	0.00557	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00112	0.00548	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.0011	0.00536	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—DPYD—head and neck cancer	0.00109	0.00534	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—CCND1—head and neck cancer	0.00107	0.00525	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—head and neck cancer	0.00107	0.00521	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—EGFR—head and neck cancer	0.00107	0.00521	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—BCL2—head and neck cancer	0.00106	0.0052	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—YAP1—head and neck cancer	0.00104	0.00507	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—EGFR—head and neck cancer	0.00104	0.00506	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—head and neck cancer	0.00103	0.00504	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—STAT3—head and neck cancer	0.00103	0.00502	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—head and neck cancer	0.00101	0.00495	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—head and neck cancer	0.00101	0.00495	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—head and neck cancer	0.000998	0.00488	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL2—head and neck cancer	0.000988	0.00483	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MAPK3—head and neck cancer	0.000982	0.0048	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000969	0.00474	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000963	0.00471	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK3—head and neck cancer	0.000959	0.00469	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—head and neck cancer	0.000954	0.00466	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—IL2—head and neck cancer	0.000936	0.00458	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—MAPK1—head and neck cancer	0.000934	0.00457	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—EGFR—head and neck cancer	0.000934	0.00456	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—STAT3—head and neck cancer	0.000928	0.00453	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—MAPK1—head and neck cancer	0.000912	0.00446	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—UROD—head and neck cancer	0.000906	0.00443	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—PIK3CA—head and neck cancer	0.000899	0.00439	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—MAPK3—head and neck cancer	0.000886	0.00433	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—NAT2—head and neck cancer	0.000864	0.00422	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000857	0.00419	CbGpPWpGaD
L-Arginine—NOS2—AGE/RAGE pathway—AKT1—head and neck cancer	0.000853	0.00417	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000853	0.00417	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—MAPK1—head and neck cancer	0.000843	0.00412	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—head and neck cancer	0.000843	0.00412	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—head and neck cancer	0.000832	0.00406	CbGpPWpGaD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—AKT1—head and neck cancer	0.000827	0.00404	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—TYMS—head and neck cancer	0.000822	0.00402	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GSTM1—head and neck cancer	0.000812	0.00397	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MAPK3—head and neck cancer	0.000794	0.00388	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PIK3CA—head and neck cancer	0.000791	0.00387	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—GPX1—head and neck cancer	0.000778	0.0038	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—CYP1A1—head and neck cancer	0.00077	0.00376	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—DPYD—head and neck cancer	0.000758	0.0037	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—MAPK1—head and neck cancer	0.000756	0.00369	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—EGFR—head and neck cancer	0.000756	0.00369	CbGpPWpGaD
L-Arginine—NOS3—Thromboxane A2 receptor signaling—AKT1—head and neck cancer	0.000755	0.00369	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.000753	0.00368	CbGpPWpGaD
L-Arginine—ASL—Metabolism—TYMS—head and neck cancer	0.000752	0.00367	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GSTM1—head and neck cancer	0.000743	0.00363	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—YAP1—head and neck cancer	0.000719	0.00351	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.000716	0.0035	CbGpPWpGaD
L-Arginine—ASL—Metabolism—GPX1—head and neck cancer	0.000711	0.00348	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—head and neck cancer	0.000705	0.00345	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CYP1A1—head and neck cancer	0.000704	0.00344	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—head and neck cancer	0.000677	0.00331	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—MAPK3—head and neck cancer	0.000667	0.00326	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—VEGFA—head and neck cancer	0.000666	0.00325	CbGpPWpGaD
L-Arginine—NOS3—AGE/RAGE pathway—AKT1—head and neck cancer	0.000662	0.00324	CbGpPWpGaD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—head and neck cancer	0.000647	0.00316	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—MAPK1—head and neck cancer	0.000635	0.0031	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—head and neck cancer	0.000634	0.0031	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—MAPK3—head and neck cancer	0.00063	0.00308	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TYMS—head and neck cancer	0.000623	0.00304	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GSTM1—head and neck cancer	0.000616	0.00301	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—head and neck cancer	0.000607	0.00297	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—MAPK1—head and neck cancer	0.000599	0.00293	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—head and neck cancer	0.000598	0.00292	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GPX1—head and neck cancer	0.00059	0.00288	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CYP1A1—head and neck cancer	0.000584	0.00285	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—head and neck cancer	0.00056	0.00274	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PIK3CA—head and neck cancer	0.000551	0.00269	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PIK3CA—head and neck cancer	0.00052	0.00254	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—head and neck cancer	0.00051	0.00249	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000508	0.00248	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—STAT3—head and neck cancer	0.000501	0.00245	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—head and neck cancer	0.000481	0.00235	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—head and neck cancer	0.000458	0.00224	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—MAPK1—head and neck cancer	0.000455	0.00223	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—head and neck cancer	0.000455	0.00223	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—head and neck cancer	0.00045	0.0022	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMS—head and neck cancer	0.000432	0.00211	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GSTM1—head and neck cancer	0.000427	0.00209	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—head and neck cancer	0.000425	0.00208	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—head and neck cancer	0.000419	0.00205	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—head and neck cancer	0.000414	0.00203	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GPX1—head and neck cancer	0.000409	0.002	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CYP1A1—head and neck cancer	0.000405	0.00198	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—head and neck cancer	0.000399	0.00195	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NAT2—head and neck cancer	0.000376	0.00184	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KISS1—head and neck cancer	0.00037	0.00181	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—head and neck cancer	0.000366	0.00179	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—head and neck cancer	0.000365	0.00179	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—head and neck cancer	0.000347	0.0017	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—DPYD—head and neck cancer	0.00033	0.00161	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	0.000323	0.00158	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—YAP1—head and neck cancer	0.000313	0.00153	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—IL2—head and neck cancer	0.000308	0.00151	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRP—head and neck cancer	0.000305	0.00149	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—head and neck cancer	0.000303	0.00148	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT6—head and neck cancer	0.000296	0.00145	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—head and neck cancer	0.000282	0.00138	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—head and neck cancer	0.000262	0.00128	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—YAP1—head and neck cancer	0.000262	0.00128	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—head and neck cancer	0.000258	0.00126	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK3—head and neck cancer	0.000248	0.00121	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—head and neck cancer	0.000241	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IL2—head and neck cancer	0.000239	0.00117	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—MAPK1—head and neck cancer	0.000236	0.00115	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—head and neck cancer	0.00023	0.00112	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOTCH1—head and neck cancer	0.000217	0.00106	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—head and neck cancer	0.000214	0.00104	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—head and neck cancer	0.000211	0.00103	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—head and neck cancer	0.00021	0.00103	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—head and neck cancer	0.000205	0.001	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—head and neck cancer	0.000203	0.000994	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—head and neck cancer	0.000198	0.000968	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK3—head and neck cancer	0.000192	0.000941	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—head and neck cancer	0.000189	0.000925	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—head and neck cancer	0.000188	0.000918	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GSTM1—head and neck cancer	0.000186	0.000908	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—MAPK1—head and neck cancer	0.000183	0.000895	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPX1—head and neck cancer	0.000178	0.000869	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP1A1—head and neck cancer	0.000176	0.000861	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—head and neck cancer	0.000174	0.000853	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOTCH1—head and neck cancer	0.000168	0.000823	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—head and neck cancer	0.000167	0.000817	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—head and neck cancer	0.000161	0.000787	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—head and neck cancer	0.000159	0.000777	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—head and neck cancer	0.000154	0.000751	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—head and neck cancer	0.000148	0.000723	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—head and neck cancer	0.000147	0.000718	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—head and neck cancer	0.00014	0.000686	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—head and neck cancer	0.00013	0.000634	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—head and neck cancer	0.000126	0.000614	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—head and neck cancer	0.000125	0.000611	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—head and neck cancer	0.000121	0.000591	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK3—head and neck cancer	0.00012	0.000586	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH1—head and neck cancer	0.000118	0.000576	CbGpPWpGaD
L-Arginine—NOS2—Disease—MAPK1—head and neck cancer	0.000114	0.000558	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—head and neck cancer	0.000114	0.000558	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—head and neck cancer	0.000109	0.000533	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—head and neck cancer	0.000105	0.000512	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—head and neck cancer	9.91e-05	0.000484	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—head and neck cancer	9.75e-05	0.000477	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK3—head and neck cancer	9.32e-05	0.000455	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—head and neck cancer	9.17e-05	0.000448	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—head and neck cancer	9.13e-05	0.000446	CbGpPWpGaD
L-Arginine—NOS3—Disease—MAPK1—head and neck cancer	8.87e-05	0.000433	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—head and neck cancer	8.86e-05	0.000433	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL2—head and neck cancer	8.12e-05	0.000397	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—head and neck cancer	8.09e-05	0.000396	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—head and neck cancer	7.91e-05	0.000387	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—head and neck cancer	7.69e-05	0.000376	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—head and neck cancer	7.64e-05	0.000373	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—head and neck cancer	7.12e-05	0.000348	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—head and neck cancer	6.9e-05	0.000337	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—head and neck cancer	6.83e-05	0.000334	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK3—head and neck cancer	6.52e-05	0.000319	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—head and neck cancer	6.44e-05	0.000315	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—head and neck cancer	6.28e-05	0.000307	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MAPK1—head and neck cancer	6.21e-05	0.000303	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—head and neck cancer	6.21e-05	0.000303	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—head and neck cancer	5.39e-05	0.000263	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—head and neck cancer	5.26e-05	0.000257	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—head and neck cancer	5.21e-05	0.000255	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—head and neck cancer	4.98e-05	0.000244	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—head and neck cancer	4.4e-05	0.000215	CbGpPWpGaD
